You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

An Endorsement of the 2017 European Association for Neuro-Oncology (EANO) Guideline on the Diagnosis and Treatment of Adult Astrocytic and Oligodendroglial Gliomas

ID: GL END 9-10 Aug 2018
Type of Content: Guidelines & Advice, Clinical
J. Perry, J. Brown, L-C. Ang, S. Das, N. Laperriere, W. Mason, D. Macdonald, G. Nicholas, H. Soliman, G. Zadeh, and the EANO Gliomas Guideline Endorsement Expert Panel

Guideline Objective

The objectives of this guideline are to provide clinical practice recommendations for the treatment of astrocytic and oligodendroglial gliomas. Our recommendations are based on the 2017 European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

Patient Population

Patients with astrocytic and oligodendroglial gliomas

Intended Guideline Users

Neurologists, neuro-oncologists, medical oncologists, radiation oncologists, neuropathologists, and neurosurgeons involved in the management of astrocytic and oligodendroglial gliomas.

Research Questions


pdf download Full Report (PDF) (686.4 KB)